Category Specific RSS

News

DomaCom to offer investors $250m in affordable housing for essential workers

Essential workers will soon have more affordable housing in the coming years with DomaCom (ASX: DCL) partnering with BlueCHP to…

6 years ago

Watch: Healthia adds optometry and audiology to allied healthcare network

Having announced the acquisition of The Optical Company and its 41 optometry clinics, Healthia (ASX: HLA) Chairman Glen Richards and…

6 years ago

IBM flags Dubber tech to be “Best of Breed” in new partnership

Aussie communications tech company Dubber (ASX: DUB) has been given a global tick of approval with their call recording technology…

6 years ago

ReadyTech enters justice sector with $54m acquisition of Open Office

Human resources and profiling tech company ReadyTech (ASX: RDY) is poised to instantly enter the justice sector through the acquisition…

6 years ago

Baby Bunting shipping container hijacked by dangerous Khapra beetle

Newborn and infant products retailer Baby Bunting (ASX: BBN) has potentially avoided a national catastrophe after a cluster of Khapra…

6 years ago

Hospitals back to normal as Nanosonics infection prevention sales return

Quirky pandemic sales endured by infection prevention company Nanosonics (ASX: NAN) look to have returned to normal with the resumption…

6 years ago

Infomedia redies rollout of automotive parts platform, signs Ford Europe

Aussie tech company Infomedia (ASX: IFM) is lining up international clients in readiness for the rollout of their Next Gen…

6 years ago

Novatti partners with Google Pay and Samsung Pay for Tap and Go

Digital payments and fintech company Novatti Group (ASX: NOV) has added a few more Tier 1 partners to their payments…

6 years ago

Healthia rising as leading healthcare operater with optometry expansion

Leading allied healthcare company Healthia (ASX: HLA) is set to significantly increase their services and national footprint with the $43…

6 years ago

FDA approves Imugene to commence human trial for lung cancer immunotherapy

Biopharma company Imugene (ASX: IMU) is now on their way towards commercialisation of their lung cancer treatment with approval from…

6 years ago